Who owns the OPELLA trademark?

The OPELLA trademark is owned by Opella Healthcare Switzerland AG.

What class is the OPELLA trademark registered in?

The OPELLA trademark is registered in Class 035 (Advertising, business management & retail services).

What is the serial number for OPELLA?

The USPTO serial number for OPELLA is 98303149.

What is the registration number for OPELLA?

OPELLA is registered under USPTO registration number 0.

Sealvo

Home Search: OPELLAOPELLA #98303149

Back

Updated Sep 27, 2026·29 searches this week

View on USPTO TSDR Find similar marks

OPE

USPTO Trademark Record

ABANDONED

OPELLA

SN 98303149·Reg 0·Filed Dec 07, 2023

Owner Opella Healthcare Switzerland AG

Advertising; business management, organization and administration; office functions.

OPELLA (Serial No. 98303149), Registration No. 0, is a abandoned US trademark filed on Dec 07, 2023 by Opella Healthcare Switzerland AG. This trademark covers Class 035 (Advertising, business management & retail services).

Conflict Analysis

Full conflict analysis for OPELLA (SN 98303149) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

OPELLA (Reg. #0) is an abandoned US trademark that was filed in 2023 but has since been abandoned. The mark covers Class 035 (Advertising, business management & retail services). Goods and services include Advertising; business management, organization and administration; office functions.. The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 07, 2023

SERIAL

98303149

REG#

REGISTERED

Dec 31, 1969

Filing Information

StatusABANDONED

Filing DateDec 07, 2023

Serial Number98303149

Registration No.0

Registration DateDec 31, 1969

Status DateJun 24, 2026

Published for OppositionJul 23, 2024

Filing Basis & Declarations

Standard Characters Claimed

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

First use anywhere: Aug 31, 2025

First use in commerce: Aug 31, 2025

Advertising; business management, organization and administration; office functions.

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

32 events

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Jun 24, 2026

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Jun 24, 2026

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

SU - NON-FINAL ACTION - WRITTEN

Mar 10, 2026

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Mar 10, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 10, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 09, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Mar 09, 2026

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Sep 03, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Sep 03, 2025

USE AMENDMENT FILED

SOU EXTENSION 1 GRANTED

Feb 28, 2025

SOU EXTENSION 1 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 28, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

Feb 27, 2025

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Feb 27, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Feb 27, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 27, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Feb 27, 2025

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

SOU TEAS EXTENSION RECEIVED

Feb 27, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Feb 27, 2025

SOU EXTENSION 1 FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 17, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jul 23, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 23, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 03, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 17, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 15, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 14, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 14, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Jun 12, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jun 12, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 12, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Jun 11, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 05, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 07, 2023

NEW APPLICATION ENTERED

Other Marks by Opella Healthcare Switzerland AG

Additional USPTO filings from the same owner.

OPE

OPELLA

79393733

OPELLA HEALTHCARE SWITZERLAND AG

REGISTERED

PHA

PHARMATON

79372649

Opella Healthcare Switzerland AG

REGISTERED

OPE

OPELLA HEALTHCARE

90086121

OPELLA HEALTHCARE SWITZERLAND AG

REGISTERED

G11

G115

99038160

Opella Healthcare Switzerland AG

ABANDONED

Other Marks by Jonathan M. Rixen

Additional USPTO filings handled by the same attorney of record.

THU

THUNDEROBOT

99598420

REGISTERED

98565281

REGISTERED

GOL

GOLYTEC ITS

98565295

REGISTERED

OMN

OMNI CAST WRAP

99203902

REGISTERED

OPELLA

Run a conflict check

Other Marks by Opella Healthcare Switzerland AG

Other Marks by Jonathan M. Rixen

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company